Hemostasis Today

February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
Feb 16, 2026, 15:28

Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety

Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn:

“Coronary Intravascular Lithotripsy (IVL): Clinical Performance and Safety

Coronary intravascular lithotripsy (IVL) is an established plaque-modification technique designed to facilitate optimal stent expansion in moderately to severely calcified coronary lesions. By delivering localized acoustic pressure waves through a low-pressure balloon system, IVL induces controlled microfractures in both superficial and deep calcium, improving vessel compliance while minimizing vascular trauma.

Clinical evidence from the Disrupt CAD I–IV trials demonstrates a procedural success rate of approximately 92%, defined by successful stent delivery with residual stenosis below target thresholds and absence of in-hospital major adverse cardiac events. In these studies, residual stenosis <50% was achieved in approximately 95% of treated lesions, reflecting effective calcium modification and favorable acute luminal gain.

Importantly, IVL is associated with a low incidence of serious complications, including a coronary perforation rate below 1%, which is substantially lower than that reported with some atherectomy-based strategies. This safety profile, combined with technical simplicity and a short learning curve, supports IVL as a valuable option for contemporary percutaneous coronary intervention in calcified coronary artery disease.”

Title: Shocking the Rock With Coronary Intravascular Lithotripsy in Contemporary Practice

Authors: Debabrata Dash, Anna Emily Bortnic

Read the Full Article on American College of Cardiology

Ney Carter Borges: Coronary Intravascular Lithotripsy - Clinical Performance and Safety

Stay updated with Hemostasis Today.